Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Arch Biopartners Inc
V.ARCH
Alternate Symbol(s):
ACHFF
Technology
Scientific & Technical Instruments
Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is...
LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:ARCH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 15, 2021 11:28am
Arch - Entering a new league
$Arch has always been dramatically more advanced than other junior biosciences in the Canadian market. The company has not partaken in toxic financings which limited it’s exposure to a lot of
...more
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 14, 2021 9:05pm
TD Waterhouse ranking
Arch Biopartners ranked 1 out of 60 in the biosciences sector
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Nov 12, 2021 8:27pm
RE:3.60 - Extremely Undervalued in Comparison to peers
I grabbed more shares today for one glarigg my reason, a lack of public offering !! AGN raised money - Released internal data - fell .25 -.06 APLI raised money - Released internal data - fell
...more
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 12, 2021 8:13pm
3.60 - Extremely Undervalued in Comparison to peers
The recent realization by the market has made the Arch chart look incredible, but lets no forget that we are extremely undervalued compared to our peer Current Market cap 182
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Nov 12, 2021 8:06pm
RE:RE:RE:RE:RE:RE:Manipulation
Given Phizer aquired TRIL for 2.2 billion, this would be the most current model we could compare. ARCH does have less shares outstanding and more insider ownership so I think they would have to
...more
(75)
•••
Antonius2
X
View Profile
View Bullboard History
Comment by
Antonius2
on Nov 12, 2021 7:28pm
RE:RE:RE:RE:RE:Manipulation
That is the number I was thinking of as well (hopefully 2 B USD)!
(2)
•••
2019champs
X
View Profile
View Bullboard History
Comment by
2019champs
on Nov 12, 2021 6:34pm
RE:RE:RE:RE:Manipulation
If the data is good, i don't see anything short of 2B valuation
(75)
•••
Antonius2
X
View Profile
View Bullboard History
Comment by
Antonius2
on Nov 12, 2021 5:24pm
RE:RE:RE:Manipulation
Once good news is released and verified it is unlikely that the price manipulation will continue. Without any competing drugs in the AKI space it is likely that Arch Biopartners will be courting
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Nov 12, 2021 2:20pm
Something to think about
The other day while I was driving home I saw a Hitchhiker holding a sign that said, "Heaven". So I ran him over. Seemed like a decent guy so I think he made it. Have a good weekend
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Comment by
stocksarefun
on Nov 11, 2021 12:07pm
RE:RE:Manipulation
it is a little bit frustrating. once the news is out and more buyers are here, do you think this will still be possible?
(2)
•••
2019champs
X
View Profile
View Bullboard History
Comment by
2019champs
on Nov 10, 2021 10:01pm
RE:RE:RE:182 Mil US Entry for a 20 Billion unmet market
Good point. It's a tight float. If the data is good, i don't see myself selling at $10-$15. I have been in this play for about 2 years and even if it takes another year or two to see $30-$40
...more
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 10, 2021 5:44pm
Todays House Positions
House Positions for C:ARCH from 20211110 to 20211110 House Bought $Val Ave Sold $Val Ave Net $Net
...more
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Comment by
Riverfolk
on Nov 10, 2021 5:44pm
RE:RE:182 Mil US Entry for a 20 Billion unmet market
I wont argue that there will be some trading happening on this momentum, but I have been a holder here for 4+ years and my network that controls near 2% are thinking long term. Coupled with the
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Nov 10, 2021 3:05pm
RE:182 Mil US Entry for a 20 Billion unmet market
I don't even think that most people who got into this stock care of the potential. They are just in it for short term gain and this stock is golden right now. If Phase 3 gets going and IF results
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario